Zuniga-Kennedy, Miranda
Davoren, Micah
Shuffrey, Lauren C.
Luna, Ruth Ann
Savidge, Tor
Prasad, Vinay
Anderson, George M.
Veenstra-VanderWeele, Jeremy http://orcid.org/0000-0002-6349-1076
Williams, Kent C.
Funding for this research was provided by:
Autism Speaks
Maternal and Child Health Bureau
Article History
Accepted: 27 April 2022
First Online: 21 June 2022
Declarations
:
: Dr. Veenstra-VanderWeele has received research support from the National Institute of Mental Health, the National Institute of Neurological Disorders and Stroke, the Simons Foundation, Roche, and Janssen. He has served on advisory boards/DSMB for Roche, Autism Speaks, the Brain and Behavior Research Foundation, and the Autism Biomarkers Consortium for Clinical Trials Network. He has also served as a site investigator for trials sponsored by these organizations. In the case of industry advisory boards or consulting, his employer has received payment for his time, and he does not have access to these funds. He has served as associate editor of Autism Research, as a special issue editor for Pediatrics, and on the editorial boards of JAMA Psychiatry, the Journal of Autism and Developmental Disorders, Autism, and the Journal of Neurodevelopmental Disorders. He has received honoraria from the American Academy of Child and Adolescent Psychiatry, the National Institute of Neurological Disorders and Stroke, the Royal Netherlands Academy of Science, Florida Atlantic University, the University of California, Los Angeles, Stanford University, the Child Mind Institute, Pennsylvania State University, and Cold Spring Harbor Laboratory. Dr. Tor Savidge received research funding from Merck, Nivalis, Cubist, Mead Johnson, Rebiotix, BioFire, Assembly BioSciences, and has served on the advisory board for Rebiotix and BioFire. No conflicts of interest, financial or otherwise, are declared by the other authors.